Stay updated on Dolutegravir Kinetics in Primary HIV: Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.

Latest updates to the Dolutegravir Kinetics in Primary HIV: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure has been removed. The previous Revision: v3.3.2 is no longer displayed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now shows a newer revision number (v3.3.1) replacing v3.2.0, indicating a site/system update rather than a change to study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page removes an administrative funding-status notice; the rest of the study details and navigation remain unchanged.SummaryDifference0.5%

- Check64 days agoChange DetectedThe page updates appear to be minor UI and layout adjustments; core study details such as objectives, eligibility criteria, primary and secondary outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedMajor update: add government status notice and new version v3.2.0; remove old version tag v3.1.0.SummaryDifference4%

Stay in the know with updates to Dolutegravir Kinetics in Primary HIV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.